Australian Health Review Australian Health Review Society
Journal of the Australian Healthcare & Hospitals Association
RESEARCH ARTICLE

Australia's "free-ride" in pharmaceuticals: Can it last?

Robert Kemp

Australian Health Review 19(1) 81 - 94
Published: 1996

Abstract

The pharmaceutical subsidy scheme in Australia works in the public interest bykeeping prices low while assuring access to drugs across most of the drug classes.By separating the approval to market drugs from the decision to subsidise them,the Commonwealth is able to take advantage of its position ? to ?free-ride? onresearch and development expenditure in other countries. The first part of this paperexamines the factors which allow Australia to free-ride. The second part exploressome international and domestic factors which may influence the sustainability ofthe free-riding strategy.

http://dx.doi.org/10.1071/AH960081

© AHHA 1996

PDF (279.1 KB) Export Citation